TRADING HALTED

Bausch Health Companies Inc VRX:Swiss Exchange

*Data is delayed | CHF
Last | 06/05/19 CET
21.44UNCH (UNCH)
52 week range
21.44 - 21.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.11
  • 52 Week High21.67
  • 52 Week High Date06/05/19
  • 52 Week Low21.44
  • 52 Week Low Date06/05/19

Key Stats

  • Market Cap8,933.87M
  • Shares Out359.15M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.11
  • 52 Week High21.67
  • 52 Week High Date06/05/19
  • 52 Week Low21.44
  • 52 Week Low Date06/05/19
  • Market Cap8,933.87M
  • Shares Out359.15M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-3.06
  • P/E (TTM)-7.01
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bausch Health Companies Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho...
Joseph Papa
Chairman
Sam Will
Chief Financial Officer
Christina Ackermann
Executive Vice President
Paul Herendeen
Executive Vice President
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada